ArdorComm Media Group

Thursday, June 25, 2026 10:14 AM

India Healthcare

Preventive Healthcare: Why It Matters More Than Ever

For decades, healthcare systems across the world have largely been reactive—we visit a doctor when something goes wrong. But today, that model is rapidly becoming outdated. Rising lifestyle diseases, increasing healthcare costs, and the lessons from global health crises have made one thing clear: waiting for symptoms is no longer sustainable. Preventive healthcare represents a powerful shift—from treating illness to anticipating and avoiding it altogether. It is not just a medical approach; it is a mindset, one that prioritizes long-term well-being over short-term fixes. What is Preventive Healthcare? Preventive healthcare refers to measures taken to prevent diseases before they occur or worsen. This includes: Regular health check-ups and screenings Vaccinations and immunizations Healthy lifestyle practices (diet, exercise, sleep) Mental health care and stress management Early diagnosis and timely intervention At its core, preventive care is about staying one step ahead of disease, rather than reacting after damage has been done.  Why Preventive Healthcare Matters More Than Ever 1. The Rising Burden of Lifestyle Diseases Non-communicable diseases (NCDs) such as diabetes, heart disease, and cancer are now the leading causes of death globally—and in India. In fact, over 60% of deaths in India are linked to preventable lifestyle diseases.  These diseases often develop silently over years. By the time symptoms appear, significant damage may already have occurred. Preventive healthcare helps detect risks early and delay or completely avoid disease onset. 2. Early Detection Saves Lives Many serious conditions—like cancer, hypertension, and diabetes—show little to no symptoms in early stages. Regular screenings can detect these conditions early, when they are easier and more effective to treat.  Research even suggests that routine preventive check-ups can significantly reduce mortality risk, especially for chronic diseases. In simple terms: Early detection = Better outcomes + Lower risk 3. Healthcare Costs Are Skyrocketing Medical treatment today is expensive—and chronic diseases often require lifelong management. Preventive healthcare helps reduce this burden by: Avoiding costly hospitalizations Minimizing long-term medication needs Reducing emergency interventions India alone is expected to face an economic burden of over ₹511 lakh crore due to NCDs by 2030.  Preventive care is not just good for health—it is financially smart. 4. Post-Pandemic Awareness and Behavior Shift The COVID-19 pandemic fundamentally changed how people view health. There is now greater awareness around: Immunity and hygiene Regular health monitoring Importance of vaccinations Preventive healthcare has evolved from being optional to essential, as individuals increasingly take responsibility for their own well-being. Mental Health is Finally in Focus Preventive healthcare is no longer limited to physical health. Rising stress, burnout, and anxiety have made mental health screening and care equally important. Early interventions—like counseling, mindfulness, and stress management—can prevent long-term psychological issues and improve overall quality of life.  6. Technology is Making Prevention Smarter The integration of technology is revolutionizing preventive healthcare: Wearables track heart rate, sleep, and activity AI predicts disease risks using health data Telemedicine enables early consultations Predictive analytics can now identify at-risk individuals even before symptoms appear, enabling personalized and timely interventions.  This shift is transforming healthcare from generalized treatment to personalized prevention. The Indian Context: A Critical Turning Point India is at a unique crossroads: A young population increasingly affected by lifestyle diseases Rising urbanization and sedentary lifestyles Growing healthcare costs and infrastructure gaps Historically, India has focused more on curative care, but the trend is shifting. Preventive healthcare is gaining momentum, driven by: Increased awareness Growth of digital health platforms Expansion of diagnostics and wellness sectors The preventive healthcare market in India is also growing rapidly, reflecting a broader societal shift toward proactive health management. Key Pillars of Preventive Healthcare 1. Regular Health Screenings Routine tests like blood sugar, cholesterol, and cancer screenings help detect risks early. 2. Healthy Lifestyle Choices Balanced nutrition, physical activity, and adequate sleep form the foundation of prevention. 3. Vaccination & Immunization Vaccines remain one of the most effective preventive tools in public health. 4. Mental Well-being Stress management, therapy, and emotional resilience are essential components. 5. Health Awareness & Education Informed individuals make better health decisions—prevention starts with awareness. Challenges in Adoption Despite its importance, preventive healthcare faces several barriers: Lack of awareness and health literacy Cultural tendency to seek care only when ill Accessibility issues in rural areas Perception of preventive care as an “extra cost” In reality, the cost of inaction is far greater. The Way Forward: Building a Preventive Culture To truly benefit from preventive healthcare, a collective effort is needed: Individuals must prioritize regular check-ups and healthy habits Institutions should integrate health programs and awareness initiatives Governments must invest in accessible preventive services Healthcare providers should promote early intervention models The goal is to move from a “sick-care system” to a “health-care system.” Conclusion: Prevention is the New Cure Preventive healthcare is no longer a luxury—it is a necessity in today’s fast-paced, high-risk world. It empowers individuals to take control of their health, reduces the burden on healthcare systems, and ensures a better quality of life. The future of healthcare lies not in hospitals alone, but in daily choices, early actions, and informed decisions. Because ultimately, the most effective treatment is the one you never need.

Preventive Healthcare: Why It Matters More Than Ever Read More »

India Tightens Oversight on GLP-1 Drugs Amid Rising Misuse Concerns

The Government of India has issued a comprehensive advisory on GLP-1 drugs, cautioning against their inappropriate use while acknowledging their growing role in managing type 2 diabetes and obesity. With demand surging—particularly for weight loss—authorities are stepping up regulation to safeguard public health. GLP-1 (Glucagon-Like Peptide-1) medications are designed to regulate blood sugar levels by enhancing insulin secretion and reducing excess glucose. They also aid in weight management by slowing digestion and curbing appetite, making them increasingly sought after beyond their primary medical purpose. However, officials have emphasized that these are not lifestyle or wellness products, but potent prescription drugs that must only be used under medical supervision. The advisory comes in response to concerns over their easy availability through online platforms and wellness clinics. Health authorities have warned that unsupervised use may lead to adverse effects, including gastrointestinal problems, hormonal disturbances, and other complications. Experts underline that these drugs are not suitable for everyone and should never be used casually for weight loss. As per the guidelines, only qualified specialists—such as endocrinologists, internal medicine physicians, and cardiologists—are authorised to prescribe GLP-1 drugs. Over-the-counter sale is strictly prohibited, and individuals are strongly advised against purchasing them without a valid prescription. Regulatory bodies, including the Drug Controller General of India (DCGI) and State Drug Controllers, have intensified inspections across pharmacies, clinics, and digital platforms. Any violations—ranging from illegal sales to misuse—will invite stringent penalties, including licence suspension and legal action. The government’s move comes at a time when the popularity of these drugs is rapidly increasing, especially as quick weight-loss solutions. Authorities aim to ensure that genuine patients retain access while preventing unsafe and unregulated usage. The advisory reinforces a critical message: GLP-1 drugs are powerful medical treatments, not shortcuts for weight loss. Responsible use, guided by medical expertise and supported by strict regulation, will be essential to ensuring patient safety in India. Source: India Today

India Tightens Oversight on GLP-1 Drugs Amid Rising Misuse Concerns Read More »

Diabetes Driving India’s Silent Liver Disease Crisis, Study Warns

A groundbreaking study has revealed that Type 2 diabetes is emerging as a major cause of advanced liver disease in India, often progressing unnoticed until it becomes life-threatening. Published in The Lancet, the DiaFib-Liver Study is the largest real-world research of its kind in a developing country, highlighting the liver as a critical yet overlooked organ at risk among diabetic patients. The study, which assessed 9,202 adults across 27 healthcare centres, found that nearly 25% of patients had significant liver fibrosis, while about 14% had advanced disease. Alarmingly, around 5% had already reached a stage suggestive of cirrhosis—despite showing no obvious symptoms. Experts note a shift in the primary causes of severe liver conditions, with diabetes and obesity now surpassing viral infections like Hepatitis B and C. The underlying mechanism involves fat accumulation in the liver, leading to insulin resistance, chronic inflammation, and eventual scarring. Interestingly, the research also challenges the belief that liver disease primarily affects overweight individuals. Cases were observed even among lean patients, with a phenomenon termed “burnt-out” liver disease—where fat diminishes as fibrosis worsens—making detection even more difficult. Given that liver damage often remains silent until advanced stages, researchers emphasize the need for improved screening. They recommend tools like the FIB-4 score, derived from routine blood tests, and FibroScan imaging for early detection, instead of relying solely on ultrasounds. Encouragingly, the study highlights that early-stage liver damage can be reversed. A 5% reduction in body weight may reverse fibrosis in many cases, while a 10% reduction can significantly slow disease progression. With India home to over 10 crore diabetics and millions more at risk, integrating liver health checks into diabetes care programs could be key to preventing a large-scale health crisis. Source: TNN

Diabetes Driving India’s Silent Liver Disease Crisis, Study Warns Read More »

AstraZeneca Secures CDSCO Approval for Expanded Use of Imfinzi in Endometrial Cancer Treatment

AstraZeneca Pharma India Ltd announced on Tuesday (February 10, 2026) that it has obtained approval from India’s drug regulator to market its cancer therapy, Durvalumab (brand name Imfinzi), for an additional indication. In a regulatory filing, the company stated that the Central Drugs Standard Control Organisation (CDSCO), under the Directorate General of Health Services, has granted permission to import, sell, and distribute Durvalumab solution for infusion in strengths of 120 mg/2.4 ml and 500 mg/10 ml for expanded therapeutic use. With this latest approval, Durvalumab can now be used in combination with chemotherapy drugs carboplatin and paclitaxel as a first-line treatment for adults diagnosed with primary advanced or recurrent endometrial cancer who are eligible for systemic therapy. Following combination treatment, the drug is also approved as a standalone maintenance therapy for patients with mismatch repair deficient (dMMR) endometrial cancer. The company noted that this regulatory clearance enables the commercial rollout of Imfinzi for the newly approved indication in India, subject to completion of other necessary statutory formalities. Source: PTI  

AstraZeneca Secures CDSCO Approval for Expanded Use of Imfinzi in Endometrial Cancer Treatment Read More »

AIIMS Delhi Installs da Vinci Robot to Train Students in Robotic Surgery

ardorcomm news

All India Institute of Medical Sciences (AIIMS), New Delhi, has taken another step forward in surgical education by setting up a da Vinci Surgical Robot at its Skills, e-Learning and Telemedicine (SET) facility. The cutting-edge system, provided by Intuitive Surgicals under a memorandum of understanding, will be used exclusively for training purposes. According to the institute, AIIMS Delhi has now become the only medical institution in the country with two dedicated training robots. Alongside the newly installed da Vinci robot, the facility already houses a Hugo training robot, supplied earlier by Medtronic. The SET facility, already popular among AIIMS trainees, faculty, and medical professionals from other institutions, provides access to simulators and manikins in a stress-free learning environment. With the addition of the da Vinci robot, the centre will further expand opportunities for medical students, residents, nurses, and surgeons to gain hands-on experience in robotic-assisted surgery across specialities such as urology, gynaecology, general surgery, oncology, and head and neck surgery. AIIMS Director Dr. M. Srinivas highlighted that robotic surgery training, which previously required surgeons to travel abroad at significant personal cost, is now available within the country. “This centre will help improve surgical precision, reduce recovery times, and elevate the standard of patient care nationwide,” he said. Echoing the sentiment, Rohitt Mahajan, Vice President and General Manager of Intuitive India, assured complete support to ensure the effective use of the new system. Dr. Amlesh Seth, Professor and Head of Urology at AIIMS, described robotic-assisted surgery as a game-changer in modern healthcare. “This training centre will enable our senior surgeons to mentor the next generation of robotic surgeons. It also offers residents early exposure to advanced techniques, helping them build confidence and prioritise patient safety before stepping into independent practice,” he added. The collaboration is expected to accelerate the adoption of robotic-assisted surgeries in India, positioning AIIMS Delhi as a hub for innovation and excellence in surgical training. Source: PTI

AIIMS Delhi Installs da Vinci Robot to Train Students in Robotic Surgery Read More »

AIIMS study reveals high prevalence of catheter-related infections in Indian hospitals

A nationwide study led by the All India Institute of Medical Sciences (AIIMS), New Delhi, has revealed that bloodstream infections linked to catheter use are widespread in intensive care units (ICUs) across India, with many cases caused by highly drug-resistant microbes. These hospital-acquired infections, known as Central Line-Associated Bloodstream Infections (CLABSI), occur when a catheter inserted into a large vein becomes contaminated. According to estimates published in The Lancet Global Health, Indian ICUs report nearly nine infection events for every 1,000 days a central line remains in use. The AIIMS-led team analysed seven years of data collected by the Indian Healthcare-Associated Infections (HAI) surveillance network, spanning 200 ICUs across 54 hospitals. Between May 2017 and April 2024, the network recorded 8,629 confirmed CLABSI cases, covering more than 3 million patient-days and nearly 1 million central line-days. The pooled CLABSI rate was found to be 8.83 per 1,000 central line-days. The study also observed a spike in infection rates during 2020–21, coinciding with the COVID-19 pandemic. Researchers attributed this surge to overburdened ICUs, staff shortages, and lapses in infection prevention practices. Experts stressed that while CLABSI is preventable, establishing systematic infection surveillance and prevention programs requires significant resources—a major challenge for low- and middle-income countries like India. Nevertheless, the findings mark the first large-scale, standardised surveillance report on CLABSI in India, offering a foundation for healthcare systems to adopt quality improvement measures. Source: PTI Photo Credit: AFP  

AIIMS study reveals high prevalence of catheter-related infections in Indian hospitals Read More »

Budget 2024: Healthcare Sector Urges Government to Boost Public Health Spending

The healthcare sector in India is advocating for increased public health spending in the upcoming Budget 2024, urging the government to raise public health expenditure above 2.5 percent of the GDP. The industry is also calling for an Ayushman Bharat-like scheme specifically for the middle class to address healthcare needs more comprehensively. Key Recommendations: Increase Public Health Expenditure: The Healthcare Federation of India (NATHEALTH) has emphasized the need for the government to boost healthcare spending to over 2.5 percent of GDP. This increase is seen as crucial for enhancing infrastructure, addressing demand and supply challenges, and improving overall social insurance. Expand Healthcare Facilities: Abhay Soi, president of NATHEALTH and chairman of Max Healthcare Institute, highlighted the necessity for two billion square feet of advanced healthcare facilities. Expanding healthcare infrastructure in smaller cities and advancing digital healthcare services are also top priorities. Comparison with Other Countries: According to the Economic Survey 2022-23, healthcare expenditure by the Centre and state governments reached 2.1 percent of GDP in FY23. In comparison, OECD data shows that the US had the highest health expenditure to GDP ratio at 16.6 percent in 2022, while India’s was at 2.9 percent. Middle-Class Healthcare Scheme: Industry leaders, including PD Hinduja Hospital CEO Gautam Khanna, suggested implementing a healthcare scheme similar to PM-JAY for the middle class. This would require allocating 2.5-3.5 percent of GDP to healthcare to ensure broader coverage and affordability. Policy Reforms and Innovations: Suneeta Reddy, Managing Director of Apollo Hospitals, emphasized the need for the government to prioritize the healthcare sector to spur growth and productivity. The industry is also advocating for easing compliance burdens, promoting medtech innovation, rationalizing the goods and services tax (GST), and reviewing the health cess on medtech products. As the first Budget of Modi 3.0 approaches, the healthcare sector’s recommendations highlight the critical need for increased investment and policy support to enhance India’s healthcare infrastructure, improve access to quality healthcare, and ensure affordability for all citizens. Boosting public health spending is seen as a vital

Budget 2024: Healthcare Sector Urges Government to Boost Public Health Spending Read More »